Le Lézard
Classified in: Health
Subject: ACC

Invitation to AAK's presentation of the second quarter 2022 on July 19


MALMO, Sweden, July 5, 2022 /PRNewswire/ -- In connection with the release of AAK's Interim report for the second quarter 2022, we invite you to a press and analyst conference to be held on Tuesday, July 19, 2022, at 1 p.m. CET. The conference will be chaired by Johan Westman, President and CEO, and Tomas Bergendahl, CFO. The presentation will be held in English.

The presentation can be followed by phone or via a webcast. Please note that questions may be asked by phone only.

To follow the conference by phone, please use one of the numbers below, followed by pin code 5685569:

SE: +46 8 505 163 86

UK: +44 20 319 84884

US: +1 412 317 6300

To follow the conference via webcast, please use the following link: https://tv.streamfabriken.com/aak-q2-2022.

It will be possible to watch the webcast after the conference call.

The presentation material will be available under the Investors tab at our website, www.aak.com. The Interim report for the second quarter 2022 will be released on July 19, 2022 at 12:00 noon CET.

For more information, please contact:

Johan Holmqvist

Head of IR and Corporate Communications

Mobile: +46 708 37 66 77

E-mail: [email protected]

The information was submitted for publication at 9:50 a.m. CET on July 5, 2022.

About AAK

Everything AAK does is about Making Better Happentm. We specialize in plant-based oils that are the value-adding ingredients in many of the products people love to consume. We make these products better tasting, healthier, and more sustainable. At the heart of AAK's offer is Customer Co-Development, combining our desire to understand what better means for each customer, with the unique flexibility of our production assets, and a deep knowledge of many products and industries, including Chocolate & Confectionery, Bakery, Dairy, Plant-based Foods, Special Nutrition, Foodservice and Personal Care. Our 4,000 employees support our close collaboration with customers through 25 regional sales offices, 15 dedicated Customer Innovation Centers, and with the support of more than 20 production facilities. Listed on Nasdaq Stockholm and with our headquarters in Malmö, Sweden, AAK has been Making Better Happen for more than 150 years.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/aak-ab/r/invitation-to-aak-s-presentation-of-the-second-quarter-2022-on-july-19,c3596381

The following files are available for download:

https://mb.cision.com/Main/871/3596381/1600846.pdf

Press release (PDF)

SOURCE AAK AB


These press releases may also interest you

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...



News published on and distributed by: